Advertisement
Table 1 Percentage of institutions receiving alerts, by measure
| CCGs | Practices | |||
|---|---|---|---|---|
| Measure | Increase alerts, % last month (mean) | Decrease alerts, % last month (mean) | Increase alerts, % last month (mean) | Decrease alerts, % last month (mean) |
| Mean alerts per month per CCG/practice | (2.5) | (2.4) | (1.3) | (1.4) |
| Mean %, all measures | 7.7 | 7.5 | 3.9 | 4.3 |
| Topical treatment of fungal nail infections | 5.3 | 6.2 | 2.1 | 2.9 |
| High-cost PPIs | 7.2 | 7.2 | 3.1 | 3.9 |
| High cost tramadol preparations | 2.4 | 3.3 | 4.6 | 4.4 |
| High-cost drugs for erectile dysfunction | 6.2 | 6.7 | 3.7 | 4.4 |
| High-cost ARBs | 6.7 | 4.3 | 2.7 | 2.7 |
| High dose inhaled corticosteroids | 14.4 | 12.9 | 5.8 | 5.1 |
| Prescribing of dipyridamole | 7.7 | 7.7 | 5.0 | 5.0 |
| Methotrexate 10 mg tablets | 5.3 | 7.7 | 2.7 | 3.1 |
| Vitamin B complex | 16.3 | 8.6 | 5.0 | 5.0 |
| Soluble/effervescent forms of paracetamol and co-codamol | 6.7 | 3.3 | 4.0 | 4.2 |
| Non-preferred NSAIDs and COX-2 inhibitors | 2.9 | 4.3 | 3.4 | 4.4 |
| Other lipid-modifying drugs | 8.1 | 6.7 | 4.7 | 3.9 |
| Direct Oral Anticoagulants (DOACs) | 14.4 | 15.3 | 4.5 | 4.9 |
| Silver dressings | 5.3 | 5.7 | 2.8 | 3.2 |
| Long-acting insulin analogues | 6.7 | 7.7 | 3.2 | 3.9 |
| Volume of antibiotic prescribing | 5.3 | 4.8 | 4.9 | 5.0 |
| Prescribing of pregabalin | 12.0 | 12.9 | 5.6 | 5.4 |
| Diltiazem preparations prescribed generically | 12.0 | 12.4 | 4.0 | 6.6 |
| Co-proxamol | 8.1 | 5.3 | 1.0 | 4.6 |
| High dose opioids | 4.8 | 6.2 | 5.8 | 5.5 |
| Ciclosporin and tacrolimus oral preparations prescribed generically | 2.9 | 5.7 | 1.4 | 2.2 |
| Desogestrel prescribed as a branded product | 11.5 | 12.4 | 4.6 | 6.2 |
| Nebivolol 2.5mg tablets | 7.2 | 6.7 | 3.1 | 2.6 |
| Three-day antibiotic courses for UTIs | 3.8 | 2.9 | 2.9 | 3.5 |
| High-cost ACE inhibitors | 2.4 | 2.4 | 1.7 | 3.0 |
| High-cost statins | 4.8 | 8.6 | 3.4 | 3.9 |
| Glaucoma eye drops prescribed by brand | 12.0 | 9.1 | 4.0 | 4.8 |
| Higher dose Proton Pump Inhibitors | 14.8 | 12.9 | 7.1 | 8.3 |
| Co-amoxiclav, cephalosporins & quinolones | 11.0 | 8.6 | 4.6 | 4.8 |
| Extended-release quetiapine | 11.5 | 7.7 | 6.2 | 5.9 |
| Short acting beta agonist inhalers | 3.8 | 8.6 | 3.5 | 3.0 |
| Keppra vs. levetiracetam | 5.3 | 4.3 | 3.3 | 2.7 |
